Frontera Therapeutics
Frontera Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
About Frontera Therapeutics
Based in the United States, Frontera Therapeutics is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Frontera Therapeutics is a clinical-stage gene therapy company that develops AAV-based gene therapies using its EXACTE capsid and transgene engineering platform. Its pipeline includes programs targeting inherited retinal diseases (e.g., RPE65 and XLRP) and it operates internationally (US and China presence).
Explore Frontera Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.